rs146762316
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000152.5(GAA):c.2156C>A(p.Ala719Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000346 in 1,594,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000152.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152212Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000143 AC: 31AN: 216742Hom.: 0 AF XY: 0.000111 AC XY: 13AN XY: 117126
GnomAD4 exome AF: 0.000362 AC: 522AN: 1442006Hom.: 0 Cov.: 33 AF XY: 0.000355 AC XY: 254AN XY: 715152
GnomAD4 genome AF: 0.000191 AC: 29AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74352
ClinVar
Submissions by phenotype
Glycogen storage disease, type II Uncertain:4Benign:1
- -
The GAA c.2156C>A; p.Ala719Glu variant (rs146762316), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 194458). This variant is found in the non-Finnish European population with an overall allele frequency of 0.03% (36/110930 alleles) in the Genome Aggregation Database. The alanine at codon 719 is weakly conserved, and computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.273). However, due to limited information, the clinical significance of the p.Ala719Glu variant is uncertain at this time. -
- -
- -
- -
not provided Uncertain:4
- -
- -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; This variant is associated with the following publications: (PMID: 22253258, 19343043) -
PM2_moderate -
GAA-related disorder Uncertain:1
The GAA c.2156C>A variant is predicted to result in the amino acid substitution p.Ala719Glu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.032% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at